Population pharmacokinetics of carboplatin, etoposide and melphalan in children: …

a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function

Duong JK, Veal GJ, Nath CE, Shaw PJ, Errington J, Ladenstein R, Boddy AV.

Br J Clin Pharmacol. 2019 Jan;85(1):136-146. doi: 10.1111/bcp.13774. Epub 2018 Nov 4. PMID: 30261554; PMCID: PMC6303207.

Previous
Previous

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in HR-NBL Patients

Next
Next

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with HR-NBL (HR-NBL1/SIOPEN ph 3 trial)